Cargando…
Hyperprogressive Disease: Main Features and Key Controversies
Along with the positioning of immunotherapy as a preferential treatment for a wide variety of neoplasms, a new pattern of response consisting in a sudden acceleration of tumor growth has been described. This phenomenon has received the name of “hyperprogressive disease”, and several definitions have...
Autores principales: | Arasanz, Hugo, Zuazo, Miren, Bocanegra, Ana, Chocarro, Luisa, Blanco, Ester, Martínez, Maite, Morilla, Idoia, Fernández, Gonzalo, Teijeira, Lucía, Morente, Pilar, Echaide, Miriam, Castro, Natalia, Fernández, Leticia, Garnica, Maider, Ramos, Pablo, Escors, David, Kochan, Grazyna, Vera, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038385/ https://www.ncbi.nlm.nih.gov/pubmed/33916696 http://dx.doi.org/10.3390/ijms22073736 |
Ejemplares similares
-
Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics
por: Arasanz, Hugo, et al.
Publicado: (2020) -
Understanding LAG-3 Signaling
por: Chocarro, Luisa, et al.
Publicado: (2021) -
Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer
por: Arasanz, Hugo, et al.
Publicado: (2022) -
CAR-T Cells for the Treatment of Lung Cancer
por: Chocarro, Luisa, et al.
Publicado: (2022) -
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors
por: Blanco, Ester, et al.
Publicado: (2023)